Previous 10 | Next 10 |
The shares of Co-Diagnostics (NASDAQ:CODX) are trading higher for the third straight session on Friday in solidarity with makers of monkeypox vaccines and therapeutics after molecular diagnostics company announced its contribution to address the virus outbreak. Co-Diagnostics (CODX) said Thur...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Emergent Biosolutions (NYSE: EBS ) – makes a proven smallpox vaccine that may be used for monkeypox Bavarian Nordic (OTCMKTS: BVNRY ) – boasts a monkeypox vaccine approved in the U.S. Inovio ...
Countries from the U.S. to Germany are planning to offer monkeypox vaccinations as the rare viral disease continues to spread outside Central and West Africa, where it is usually detected. On Tuesday, the World Health Organization (WHO) confirmed 131 monkeypox cases and another 106 suspected ...
The COVID-19 vaccine maker Moderna (NASDAQ:MRNA) announces that the company is currently investigating potential monkeypox vaccines at a pre-clinical stage. The mRNA-based vaccine developer currently runs 46 programs in its pipeline, with 34 vaccines in the development. The Cambridge, Massach...
The CDC said that it has over 1K doses of the Jynneos vaccine, made by Bavarian Nordic (OTCPK:BVNKF) (OTCPK:BVNRY), in the national stockpile and will release some of it soon, Reuters reported. Jynneos is the only U.S. FDA vaccine approved for monkeypox. In addition, the U.S. has more than 1M...
Takeover speculation and monkeypox concerns stirred trading in individual stocks during Monday's midday action. Nutanix (NTNX) received a boost from conjecture that it could become a takeover target for private equity. Meanwhile, smallpox vaccine maker Emergent Biosolutions (NYSE:EBS) garnere...
Shares of Emergent BioSolutions (NYSE: EBS) were jumping 12% as of 11:09 a.m. ET on Monday. The big gain was due to increased concerns about the spread of monkeypox. Emergent BioSolutions markets ACAM2000, a smallpox vaccine that could also help prevent monkeypox infection. The ...
Emergent BioSolutions Inc ( NYSE: EBS ) opened another 15% up in the stock market this morning as global cases of Monkeypox continued to rise over the weekend. How does the outbreak affect Emergent BioSolutions? According to the Centres for Disease Control and Prevention, AC...
Stock Market Today Mid-Morning Updates On Monday, the Dow Jones Industrial Average is up by 240 points, after it posted its first eight-week losing streak in more than 80 years. The Nasdaq and S&P 500 have also posted their seven straight losing weeks. Notably, the S&P 5...
As monkeypox cases continue to rise worldwide, a group of companies focused on therapeutics and vaccines targeted at a close relative of the virus has extended their recent gains in the pre-market on Monday. Monkeypox is a rare viral disease most common in remote parts of Central and West Afr...
News, Short Squeeze, Breakout and More Instantly...
Emergent Biosolutions Inc. Company Name:
EBS Stock Symbol:
NYSE Market:
Emergent Biosolutions Inc. Website:
New video and radio segments raise awareness of a potentially life-saving, three-step method that anyone can use to respond in a suspected opioid poisoning GAITHERSBURG, Md., July 24, 2024 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced the launch of a new opio...
GAITHERSBURG, Md., July 23, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Tuesday, August 6, 2024, at 5:00 pm eastern time to discuss the financial results for the second quarter 2024, key business updates, revenue guidance for the third quarter of...
The extension to a four-year shelf-life helps improve naloxone access as communities continue to grapple with the growing opioid epidemic; product with the extended shelf life has officially begun shipping WINNIPEG, Manitoba, July 22, 2024 (GLOBE NEWSWIRE) -- Today, Emergent BioSolution...